Tag: GCP compliance

Mapping Clinical Questions to Estimands Under ICH E9(R1)

November 18, 2025November 15, 2025 digi

Mapping Clinical Questions to Estimands Under ICH E9(R1) Mapping Clinical Questions to Estimands Under ICH E9(R1) The importance of accurately defining and interpreting estimands in clinical trial design is increasingly recognized in regulatory guidelines, particularly after the introduction of the ICH E9(R1) document, which focuses on the need to understand the clinical question being addressed….

Estimands & Handling Intercurrent Events

Oversight Models for Decentralized and Hybrid Clinical Trial Sites

November 18, 2025November 15, 2025 digi

Oversight Models for Decentralized and Hybrid Clinical Trial Sites Oversight Models for Decentralized and Hybrid Clinical Trial Sites The evolution of clinical trials has risen significantly due to technological advancements and changing patient expectations, leading to the emergence of decentralized and hybrid clinical trial models. These models offer potential benefits such as improved patient access…

Oversight of DCT/Hybrid Sites

Risk-Based Oversight of Home Health, Local Labs and Community Providers

November 18, 2025November 15, 2025 digi

Risk-Based Oversight of Home Health, Local Labs and Community Providers Risk-Based Oversight of Home Health, Local Labs and Community Providers In the ever-evolving landscape of clinical trials, particularly with the rise of decentralized clinical trials (DCT) and hybrid models, the need for effective risk-based monitoring (RBM) has never been more critical. This article provides a…

Oversight of DCT/Hybrid Sites

Audit Trails and Access Controls: Core Defenses for Clinical Data Integrity

November 18, 2025November 15, 2025 digi

Audit Trails and Access Controls: Core Defenses for Clinical Data Integrity Audit Trails and Access Controls: Core Defenses for Clinical Data Integrity In the realm of clinical trials, ensuring the integrity of data is paramount. Regulatory bodies like the FDA, EMA, and MHRA mandate stringent guidelines for data management that encompass audit trails and access…

Audit Trails & Access Controls

Configuring System Roles and Permissions to Support Least-Privilege Access

November 18, 2025November 15, 2025 digi

Configuring System Roles and Permissions to Support Least-Privilege Access In today’s clinical research landscape, especially for prostate cancer clinical trials, ensuring data integrity and security is paramount. The implementation of robust system roles and permissions aligned with the principle of least-privilege access plays a critical role in protecting sensitive data and meeting regulatory compliance standards….

Audit Trails & Access Controls

Estimands in Clinical Trials: From Concept to Implementation

November 18, 2025November 15, 2025 digi

Estimands in Clinical Trials: From Concept to Implementation Estimands in Clinical Trials: From Concept to Implementation The evolving landscape of clinical trials has introduced the concept of estimands, offering a structured framework for defining treatment effects while accounting for practical variables inherent in real-world situations. This tutorial provides an in-depth exploration of estimands, their significance,…

Estimands & Handling Intercurrent Events

Integration of Issue Management With RBM and Central Monitoring Outputs

November 18, 2025November 15, 2025 digi

Integration of Issue Management With RBM and Central Monitoring Outputs The integration of issue management with risk-based monitoring (RBM) and central monitoring outputs represents a significant advancement in clinical research services. This tutorial provides a step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals to effectively implement these strategies. By ensuring thorough oversight…

Issue Management & Escalation Paths

Designing Global vs Local Issue Management Models in Multi-Region Trials

November 18, 2025November 15, 2025 digi

Designing Global vs Local Issue Management Models in Multi-Region Trials In the complex landscape of clinical trials, especially those that span multiple regions, the design of effective issue management models is crucial for success. This article provides a comprehensive guide tailored for clinical operations, regulatory affairs, and medical affairs professionals involved in patient engagement clinical…

Issue Management & Escalation Paths

CAPA Strategies Targeting Data Integrity Root Causes

November 18, 2025November 15, 2025 digi

CAPA Strategies Targeting Data Integrity Root Causes CAPA Strategies Targeting Data Integrity Root Causes Data integrity is paramount in clinical trials, particularly in maintaining compliance with the requirements set forth by regulatory authorities such as the FDA, EMA, and MHRA. The process of developing and implementing Corrective and Preventive Action (CAPA) strategies is critical for…

Data Integrity (ALCOA++, 21 CFR Part 11)

Measuring Data Integrity Culture and Maturity in Clinical Organizations

November 18, 2025November 15, 2025 digi

Measuring Data Integrity Culture and Maturity in Clinical Organizations Measuring Data Integrity Culture and Maturity in Clinical Organizations In the evolving landscape of clinical research, understanding the significance of data integrity is paramount. This comprehensive guide will detail a step-by-step approach for clinical operations, regulatory affairs, and medical affairs professionals to assess and enhance the…

Data Integrity (ALCOA++, 21 CFR Part 11)